{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:05:43Z","timestamp":1776870343056,"version":"3.51.2"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T00:00:00Z","timestamp":1156809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the effectiveness of lithium augmentation of topiramate on mood symptoms, binge eating behavior, and body weight in obese bipolar patients with binge eating disorder (BED) seeking weight management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We conducted a naturalistic study of 12 consecutive outpatients with bipolar disorders, BED, and obesity who received lithium augmentation for mood instability during the course of topiramate\u2010based pharmacotherapy for obesity and BED. Lithium was added to topiramate (mean dose 514\u2009mg i.d.) and titrated to a mean dose of 1009\u2009mg i.d. (mean plasma concentration 0.7\u2009mmol\/L). Treatment response was assessed by comparing changes in clinical severity scales for mood and eating disorders, weekly binge eating frequency, and weight for the 2 months before and the first 2 months during lithium treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A statistically significant improvement in global severity of mood symptoms was observed after as compared to before lithium augmentation. Statistically insignificant reductions in weight and in binge frequency and severity were also observed after lithium addition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Optimal weight loss treatment in obese patients with comorbid bipolar and BEDs may require stabilization of mood. The combination of lithium and topiramate may have a role in the management of this difficult\u2010to\u2010treat population. Copyright \u00a9 2006 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hup.783","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T09:29:35Z","timestamp":1156843775000},"page":"425-431","source":"Crossref","is-referenced-by-count":17,"title":["Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity"],"prefix":"10.1002","volume":"21","author":[{"given":"Renu","family":"Kotwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Guerdjikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Paul E.","family":"Keck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8,29]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000139755.58092.03"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00144.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2003.102"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.11.2152"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.1999.10111.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2005.00248.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.112"},{"key":"e_1_2_1_11_1","unstructured":"FirstMB SpitzerRL GibbonM.et al.1996.Structured Clinical Interview for DSM\u2010IV Axis I disorders (SCID). New York New York State Psychiatric Institute Biometric Research."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.01.004"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111000-00005"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.11.1873"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-277X.1996.00444.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.10.1260"},{"key":"e_1_2_1_17_1","first-page":"45","article-title":"Treatment of bulimia with lithium: a preliminary study","volume":"23","author":"Hsu LK","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199106000-00008"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198502000-00004"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1205"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-5-19"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00276.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-7-200504050-00012"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0909"},{"key":"e_1_2_1_25_1","volume-title":"Textbook of Psychopharmacology","author":"McElroy S","year":"2004"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00316-9"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.255"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.11.008"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01189.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10038"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200206000-00020"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2004.04.014"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.5.526"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1980.tb00607.x"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0607"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.783","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:33:08Z","timestamp":1700040788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,29]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1002\/hup.783"],"URL":"https:\/\/doi.org\/10.1002\/hup.783","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,29]]}}}